MoneyWorks4Me

Zydus Lifesciences informs about press release

13 Oct 2026 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated October 13, 2026, titled ‘Zydus and Formycon: FYB206 Becomes First Publicly Announced Keytruda® Biosimilar Accepted for Review by USFDA’.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..